De Boelelaan, Netherlands

Tuna Mutis

This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Janssen Biotech, Inc.. Active years: 2020-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tuna Mutis. Retrieved from https://idiyas.com/inventor/tuna-mutis-c4jr9won

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 38(Granted Patents)


Location History:

  • Zoeterwoude, NL (2020)
  • De Boelelaan, NL (2020 - 2021)

Company Filing History:


Years Active: 2020-2021

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Tuna Mutis: Innovator in Immunotherapy

Introduction

Tuna Mutis is a prominent inventor based in De Boelelaan, Netherlands. He has made significant contributions to the field of immunotherapy, particularly in the treatment of solid tumors and hematological malignancies. With a total of 3 patents to his name, his work is paving the way for innovative cancer treatments.

Latest Patents

One of Tuna Mutis's latest patents focuses on immune modulation and the treatment of solid tumors with antibodies that specifically bind CD38. This invention relates to methods of immunomodulation aimed at treating patients with solid tumors. Another notable patent involves combination therapies for hematological malignancies using anti-CD38 antibodies and survivin inhibitors. This invention addresses the need for effective combination therapies in treating blood cancers.

Career Highlights

Tuna Mutis is currently associated with Janssen Biotech, Inc., where he continues to advance his research in immunotherapy. His work has garnered attention for its potential to improve patient outcomes in cancer treatment.

Collaborations

Tuna has collaborated with esteemed colleagues such as Henk Lokhorst and Niels Van De Donk, contributing to a rich environment of innovation and research in the field of oncology.

Conclusion

Tuna Mutis stands out as a key figure in the development of novel cancer therapies. His patents reflect a commitment to improving treatment options for patients facing challenging diagnoses.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…